NCT06057454View on ClinicalTrials.gov

R-5280 in Newly Diagnosed Patients With Type 1 Diabetes

PHASE1RecruitingINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

December 5, 2023

Primary Completion Date

May 31, 2025

Study Completion Date

September 30, 2025

Conditions
Type 1 DiabetesType 1 Diabetes (Juvenile Onset)Diabetes Mellitus, Type 1
Interventions
DRUG

R-5280

Modified Superior Starch

OTHER

Placebo

Food Grade Starch

Trial Locations (3)

33317

RECRUITING

Edward Jenner Research Group LLC, Plantation

55905

RECRUITING

Mayo Clinic, Rochester

75390

RECRUITING

UTSW Medical Center, Dallas

All Listed Sponsors
lead

Rise Therapeutics LLC

INDUSTRY